Trial Profile
EFFECTS OF SAPROPTERIN ON PORTAL AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION: A BICENTRIC DOUBLE-BLIND PLACEBO CONTROLLED STUDY
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2015
Price :
$35
*
At a glance
- Drugs Sapropterin (Primary)
- Indications Portal hypertension
- Focus Adverse reactions; Therapeutic Use
- 05 May 2014 New trial record
- 09 Apr 2014 Results presented at the 49th Annual Meeting of the European Association for the Study of the Liver.